GlassScriptPhysician profile
Peggy Dawn Eckler
NPI 1649619008
$9,163.15
in general payments reported to CMS, 2019-2025
15 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,487 · 2022: $3,689 · 2023: $1,368 · 2024: $1,334 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,908 · Travel and Lodging: $79.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,907.99 |
| Travel and Lodging | $79.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,898.51 | 2022-2025 | Mitraclip, Navitor, Triclip |
| Edwards Lifesciences Corporation | $3,491.68 | 2021-2025 | Evoque, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $1,023.25 | 2022 | |
| Medtronic, INC. | $364.62 | 2022-2025 | Corevalve Evolut R |
| Pfizer INC. | $82.89 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $46.71 | 2023-2024 | Xarelto |
| Scpharmaceuticals INC. | $42.32 | 2024 | |
| Novartis Pharmaceuticals Corporation | $39.21 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.38 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $27.68 | 2024 | Wainua |
| W. L. Gore & Associates, INC. | $25.53 | 2024 | Gore Cardioform Septal Occluder |
| Novo Nordisk INC | $23.81 | 2024 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.57 | 2024 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $19.33 | 2024 | |
| Amgen INC. | $18.66 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peggy Eckler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.